Senior insider sale
Chief Scientific Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.73M
56.94K shares
What this filing means
LILLIE JAMES WOODRUFF plans to sell 56.94K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.73M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001974158-26-000064
Officer· Chief Scientific Officer
Since Feb 2026
56.94K
Shares to sell
$1.73M
Approx. market value
52.43K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vested RSU
N/A
7/5/2024
52.43KTotal acquired52.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/5/2024 | Vested RSU N/A | 52.43K | — |
| Total | 52.43K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.78K
Market value
$76.2K
4/16/2026
—Completed
Units to sell
1.73K
Market value
$46.4K
4/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
52.43K
Market value
$1.61M
5/4/2026
Total
Units
56.94K
Value
$1.73M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 2.78K | $76.2K | — | Completed |
4/15/2026 | 1.73K | $46.4K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 52.43K | $1.61M | NASDAQ | Planned |
| Total | 56.94K | $1.73M | ||